Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Serotonin Uptake Inhibitors

Known as: Uptake Inhibitors, 5 Hydroxytryptamine, Reuptake Inhibitors, Serotonin, Inhibitors, 5-HT Uptake 
Compounds that specifically inhibit the reuptake of serotonin in the brain.
National Institutes of Health

Related topics

Related topics

40 relations

Narrower (26)

AmoxapineCitalopramClomipramineFenclonine
Expand
Antidepressive Agents, Second-GenerationIn BloodReceptors, Serotonin, 5-HT2Serotonin 5-HT-3 Receptor
Expand

Broader (2)

Serotonin Antagonistsneurotransmitter antagonist

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
A decade of clinical development of PARP inhibitors in perspective
Abstract Genomic instability is a hallmark of cancer, and often is the result of altered DNA repair capacities in tumour cells… Expand
  • figure 1
  • figure 2
  • figure 3
Review
2019
Review
2019
The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS) which initiates rapid signal… Expand
Review
2019
Review
2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Rationale & ObjectiveThe approved therapeutic indication for immune checkpoint inhibitors (CPIs) are rapidly expanding including… Expand
Review
2019
Review
2019
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
Poly (ADP-ribose) polymerases (PARPs) play an important role in various cellular processes, such as replication, recombination… Expand
  • figure 1
  • figure 2
  • table 1
Review
2019
Review
2019
Exploring and comparing adverse events between PARP inhibitors.
Ovarian cancer remains one of the most challenging malignancies to treat. Targeted therapies such as poly (ADP-ribose) polymerase… Expand
Review
2019
Review
2019
Environmental risk factors and biomarkers for autism spectrum disorder: an umbrella review of the evidence.
BACKGROUND Numerous studies have identified potential risk factors and biomarkers for autism spectrum disorder. We aimed to study… Expand
  • figure 2
  • table 1
  • table 2
Review
2018
Review
2018
Biomarkers for Homologous Recombination Deficiency in Cancer
Defective DNA repair is a common hallmark of cancer. Homologous recombination is a DNA repair pathway of clinical interest due to… Expand
  • figure 1
Review
2018
Review
2018
Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes.
OBJECTIVES The aim of Working Group 1 was to address the influence of different local (implant length, diameter, and design) and… Expand
Review
2018
Review
2018
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Phosphodiesterase-4 (PDE4), mainly present in immune cells, epithelial cells, and brain cells, manifests as an intracellular non… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Review
2017
Review
2017
The effects of maternal antidepressant use on offspring behaviour and brain development: Implications for risk of neurodevelopmental disorders
Approximately 10% of pregnant women are prescribed antidepressant drugs (ADDs), with selective serotonin reuptake inhibitors… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE